Equity Rank computed model fair value for DXCM from 9 independent valuation methods with sufficient data. 1 place fair value above the current price of $89.48, and 8 place it below. The model-blended estimate lands at $69.82 — a model fair value differential of 22.0% below the current price under these model assumptions. The larger group places fair value below the current price.
Equity Rank's fundamental strength composite scores DXCM at 78.7/100 (A-, Strong), blending profitability, balance-sheet, and cash-flow quality. Over the trailing three years, free cash flow has compounded at +52.3% per year and gross margin has moved -4.6 pp. Its SAVE composite score has moved -1.8 over the past 30 days.
DexCom Inc (DXCM) is analyzed on Equity Rank using the S·A·V·E framework: Sentiment, Analyst consensus, Valuation (DCF, Graham, multiples), and Earnings quality. The consensus fair value is a blend of multiple models designed to surface potential mispricings versus current market price.
Equity Rank provides institutional-depth valuation research on 3,000+ US equities. Data is refreshed daily and combines quantitative models with AI-driven qualitative analysis.
All Healthcare stocks with model fair values · Undervalued Healthcare stocks
Intrinsic Value Calculator · DCF Calculator · Margin of Safety Calculator
Data study: 19 valuation models across 3,091 US stocks · Compare any two stocks